Pfizer-BioNTech Covid-19 Vaccine Dose 2 - CDT Code Guide
Overview
CDT Code D1714 pertains to the administration of the Pfizer-BioNTech Covid-19 vaccine, specifically the second dose for pediatric patients. This procedure involves administering a 10mcg/0.2mL dose of the mRNA vaccine with a tris-sucrose formulation intramuscularly. It is crucial in the preventive care category, aimed at protecting children from the SARS-CoV-2 virus. Dental professionals may encounter this code when coordinating care with medical providers or when involved in community health initiatives. Understanding this code is essential for ensuring proper billing and compliance in practices that offer vaccination services.
When to Use This Code
- Administering the second dose of the Pfizer-BioNTech Covid-19 vaccine to pediatric patients
- Coordinating with medical providers for comprehensive patient care
- Participating in community health outreach programs offering vaccinations
- Documenting vaccine administration in dental settings involved in public health initiatives
Documentation Requirements
- Patient's full name and date of birth
- Date and time of vaccine administration
- Lot number and expiration date of the vaccine
- Site of administration and dosage
- Consent form signed by parent or guardian
Billing Considerations
Ensure the correct use of CDT code D1714 for the second dose. Verify insurance coverage for vaccine administration, as some plans may have specific requirements. Be aware of frequency limitations and ensure that the first dose has been properly documented. Common modifiers may include those indicating the patient's age or special circumstances.
Related CDT Codes
Frequently Asked Questions
No, D1714 is specifically for the administration of the second dose of the Pfizer-BioNTech Covid-19 vaccine for pediatric patients.
Need help with dental coding?
Our AI-powered assistant can answer your CDT code questions instantly.